Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

SB 512Session 2025

Medical Marijuana Edibles

S 512 Filed

Underlined text would be added to current law. Struck-through text would be removed.

Florida Senate - 2025 SB 512 By Senator Harrell 31-00878-25 2025512__ 1 A bill to be entitled 2 An act relating to medical marijuana edibles; amending 3 s. 381.986, F.S.; revising the packaging and labeling 4 requirements for medical marijuana edibles; providing 5 an effective date. 6 7 Be It Enacted by the Legislature of the State of Florida: 8 9 Section 1. Paragraph (e) of subsection (8) of section 10 381.986, Florida Statutes, is amended to read: 11 381.986 Medical use of marijuana.— 12 (8) MEDICAL MARIJUANA TREATMENT CENTERS.— 13 (e) A licensed medical marijuana treatment center shall 14 cultivate, process, transport, and dispense marijuana for 15 medical use. A licensed medical marijuana treatment center may 16 not contract for services directly related to the cultivation, 17 processing, and dispensing of marijuana or marijuana delivery 18 devices, except that a medical marijuana treatment center 19 licensed pursuant to subparagraph (a)1. may contract with a 20 single entity for the cultivation, processing, transporting, and 21 dispensing of marijuana and marijuana delivery devices. A 22 licensed medical marijuana treatment center must, at all times, 23 maintain compliance with the criteria demonstrated and 24 representations made in the initial application and the criteria 25 established in this subsection. Upon request, the department may 26 grant a medical marijuana treatment center a variance from the 27 representations made in the initial application. Consideration 28 of such a request shall be based upon the individual facts and 29 circumstances surrounding the request. A variance may not be 30 granted unless the requesting medical marijuana treatment center 31 can demonstrate to the department that it has a proposed 32 alternative to the specific representation made in its 33 application which fulfills the same or a similar purpose as the 34 specific representation in a way that the department can 35 reasonably determine will not be a lower standard than the 36 specific representation in the application. A variance may not 37 be granted from the requirements in subparagraph 2. and 38 subparagraphs (b)1. and 2. 39 1. A licensed medical marijuana treatment center may 40 transfer ownership to an individual or entity who meets the 41 requirements of this section. A publicly traded corporation or 42 publicly traded company that meets the requirements of this 43 section is not precluded from ownership of a medical marijuana 44 treatment center. To accommodate a change in ownership: 45 a. The licensed medical marijuana treatment center shall 46 notify the department in writing at least 60 days before the 47 anticipated date of the change of ownership. 48 b. The individual or entity applying for initial licensure 49 due to a change of ownership must submit an application that 50 must be received by the department at least 60 days before the 51 date of change of ownership. 52 c. Upon receipt of an application for a license, the 53 department shall examine the application and, within 30 days 54 after receipt, notify the applicant in writing of any apparent 55 errors or omissions and request any additional information 56 required. 57 d. Requested information omitted from an application for 58 licensure must be filed with the department within 21 days after 59 the department’s request for omitted information or the 60 application shall be deemed incomplete and shall be withdrawn 61 from further consideration and the fees shall be forfeited. 62 e. Within 30 days after the receipt of a complete 63 application, the department shall approve or deny the 64 application. 65 2. A medical marijuana treatment center, and any individual 66 or entity who directly or indirectly owns, controls, or holds 67 with power to vote 5 percent or more of the voting shares of a 68 medical marijuana treatment center, may not acquire direct or 69 indirect ownership or control of any voting shares or other form 70 of ownership of any other medical marijuana treatment center. 71 3. A medical marijuana treatment center may not enter into 72 any form of profit-sharing arrangement with the property owner 73 or lessor of any of its facilities where cultivation, 74 processing, storing, or dispensing of marijuana and marijuana 75 delivery devices occurs. 76 4. All employees of a medical marijuana treatment center 77 must be 21 years of age or older and have passed a background 78 screening pursuant to subsection (9). 79 5. Each medical marijuana treatment center must adopt and 80 enforce policies and procedures to ensure employees and 81 volunteers receive training on the legal requirements to 82 dispense marijuana to qualified patients. 83 6. When growing marijuana, a medical marijuana treatment 84 center: 85 a. May use pesticides determined by the department, after 86 consultation with the Department of Agriculture and Consumer 87 Services, to be safely applied to plants intended for human 88 consumption, but may not use pesticides designated as 89 restricted-use pesticides pursuant to s. 487.042. 90 b. Must grow marijuana within an enclosed structure and in 91 a room separate from any other plant. 92 c. Must inspect seeds and growing plants for plant pests 93 that endanger or threaten the horticultural and agricultural 94 interests of the state in accordance with chapter 581 and any 95 rules adopted thereunder. 96 d. Must perform fumigation or treatment of plants, or 97 remove and destroy infested or infected plants, in accordance 98 with chapter 581 and any rules adopted thereunder. 99 7. Each medical marijuana treatment center must produce and 100 make available for purchase at least one low-THC cannabis 101 product. 102 8. A medical marijuana treatment center that produces 103 edibles must hold a permit to operate as a food establishment 104 pursuant to chapter 500, the Florida Food Safety Act, and must 105 comply with all the requirements for food establishments 106 pursuant to chapter 500 and any rules adopted thereunder. 107 Edibles may not contain more than 200 milligrams of 108 tetrahydrocannabinol, and a single serving portion of an edible 109 may not exceed 10 milligrams of tetrahydrocannabinol. Edibles 110 may have a potency variance of no greater than 15 percent. 111 Marijuana products, including edibles, may not be attractive to 112 children; be manufactured in the shape of humans, cartoons, or 113 animals; be manufactured in a form that bears any reasonable 114 resemblance to products available for consumption as 115 commercially available candy; or contain any color additives. To 116 discourage consumption of edibles by children, the department 117 shall determine by rule any shapes, forms, and ingredients 118 allowed and prohibited for edibles. Medical marijuana treatment 119 centers may not begin processing or dispensing edibles until 120 after the effective date of the rule. The department shall also 121 adopt sanitation rules providing the standards and requirements 122 for the storage, display, or dispensing of edibles. 123 9. Within 12 months after licensure, a medical marijuana 124 treatment center must demonstrate to the department that all of 125 its processing facilities have passed a Food Safety Good 126 Manufacturing Practices, such as Global Food Safety Initiative 127 or equivalent, inspection by a nationally accredited certifying 128 body. A medical marijuana treatment center must immediately stop 129 processing at any facility which fails to pass this inspection 130 until it demonstrates to the department that such facility has 131 met this requirement. 132 10. A medical marijuana treatment center that produces 133 prerolled marijuana cigarettes may not use wrapping paper made 134 with tobacco or hemp. 135 11. When processing marijuana, a medical marijuana 136 treatment center must: 137 a. Process the marijuana within an enclosed structure and 138 in a room separate from other plants or products. 139 b. Comply with department rules when processing marijuana 140 with hydrocarbon solvents or other solvents or gases exhibiting 141 potential toxicity to humans. The department shall determine by 142 rule the requirements for medical marijuana treatment centers to 143 use such solvents or gases exhibiting potential toxicity to 144 humans. 145 c. Comply with federal and state laws and regulations and 146 department rules for solid and liquid wastes. The department 147 shall determine by rule procedures for the storage, handling, 148 transportation, management, and disposal of solid and liquid 149 waste generated during marijuana production and processing. The 150 Department of Environmental Protection shall assist the 151 department in developing such rules. 152 d. Test the processed marijuana using a medical marijuana 153 testing laboratory before it is dispensed. Results must be 154 verified and signed by two medical marijuana treatment center 155 employees. Before dispensing, the medical marijuana treatment 156 center must determine that the test results indicate that low 157 THC cannabis meets the definition of low-THC cannabis, the 158 concentration of tetrahydrocannabinol meets the potency 159 requirements of this section, the labeling of the concentration 160 of tetrahydrocannabinol and cannabidiol is accurate, and all 161 marijuana is safe for human consumption and free from 162 contaminants that are unsafe for human consumption. The 163 department shall determine by rule which contaminants must be 164 tested for and the maximum levels of each contaminant which are 165 safe for human consumption. The Department of Agriculture and 166 Consumer Services shall assist the department in developing the 167 testing requirements for contaminants that are unsafe for human 168 consumption in edibles. The department shall also determine by 169 rule the procedures for the treatment of marijuana that fails to 170 meet the testing requirements of this section, s. 381.988, or 171 department rule. The department may select samples of marijuana 172 from a medical marijuana treatment center facility which shall 173 be tested by the department to determine whether the marijuana 174 meets the potency requirements of this section, is safe for 175 human consumption, and is accurately labeled with the 176 tetrahydrocannabinol and cannabidiol concentration or to verify 177 the result of marijuana testing conducted by a marijuana testing 178 laboratory. The department may also select samples of marijuana 179 delivery devices from a medical marijuana treatment center to 180 determine whether the marijuana delivery device is safe for use 181 by qualified patients. A medical marijuana treatment center may 182 not require payment from the department for the sample. A 183 medical marijuana treatment center must recall marijuana, 184 including all marijuana and marijuana products made from the 185 same batch of marijuana, that fails to meet the potency 186 requirements of this section, that is unsafe for human 187 consumption, or for which the labeling of the 188 tetrahydrocannabinol and cannabidiol concentration is 189 inaccurate. The department shall adopt rules to establish 190 marijuana potency variations of no greater than 15 percent using 191 negotiated rulemaking pursuant to s. 120.54(2)(d) which accounts 192 for, but is not limited to, time lapses between testing, testing 193 methods, testing instruments, and types of marijuana sampled for 194 testing. The department may not issue any recalls for product 195 potency as it relates to product labeling before issuing a rule 196 relating to potency variation standards. A medical marijuana 197 treatment center must also recall all marijuana delivery devices 198 determined to be unsafe for use by qualified patients. The 199 medical marijuana treatment center must retain records of all 200 testing and samples of each homogeneous batch of marijuana for 201 at least 9 months. The medical marijuana treatment center must 202 contract with a marijuana testing laboratory to perform audits 203 on the medical marijuana treatment center’s standard operating 204 procedures, testing records, and samples and provide the results 205 to the department to confirm that the marijuana or low-THC 206 cannabis meets the requirements of this section and that the 207 marijuana or low-THC cannabis is safe for human consumption. A 208 medical marijuana treatment center shall reserve two processed 209 samples from each batch and retain such samples for at least 9 210 months for the purpose of such audits. A medical marijuana 211 treatment center may use a laboratory that has not been 212 certified by the department under s. 381.988 until such time as 213 at least one laboratory holds the required certification, but in 214 no event later than July 1, 2018. 215 e. Package the marijuana in compliance with the United 216 States Poison Prevention Packaging Act of 1970, 15 U.S.C. ss. 217 1471 et seq. 218 f. Package the marijuana in a receptacle that has a firmly 219 affixed and legible label stating the following information: 220 (I) The marijuana or low-THC cannabis meets the 221 requirements of sub-subparagraph d. 222 (II) The name of the medical marijuana treatment center 223 from which the marijuana originates. 224 (III) The batch number and harvest number from which the 225 marijuana originates and the date dispensed. 226 (IV) The name of the physician who issued the physician 227 certification. 228 (V) The name of the patient. 229 (VI) The product name, if applicable, and dosage form, 230 including concentration of tetrahydrocannabinol and cannabidiol. 231 The product name may not contain wording commonly associated 232 with products that are attractive to children or which promote 233 the recreational use of marijuana. 234 (VII) The recommended dose. 235 (VIII) A warning that it is illegal to transfer medical 236 marijuana to another person. 237 (IX) A marijuana universal symbol developed by the 238 department. 239 12. The medical marijuana treatment center shall include in 240 each package a patient package insert with information on the 241 specific product dispensed related to: 242 a. Clinical pharmacology. 243 b. Indications and use. 244 c. Dosage and administration. 245 d. Dosage forms and strengths. 246 e. Contraindications. 247 f. Warnings and precautions. 248 g. Adverse reactions. 249 13. In addition to the packaging and labeling requirements 250 specified in subparagraphs 11. and 12., marijuana in a form for 251 smoking must be packaged in a sealed receptacle with a legible 252 and prominent warning to keep away from children and a warning 253 that states marijuana smoke contains carcinogens and may 254 negatively affect health. Such receptacles for marijuana in a 255 form for smoking must be plain, opaque, and white without 256 depictions of the product or images other than the medical 257 marijuana treatment center’s department-approved logo and the 258 marijuana universal symbol. 259 14. The department shall adopt rules to regulate the types, 260 appearance, and labeling of marijuana delivery devices dispensed 261 from a medical marijuana treatment center. The rules must 262 require marijuana delivery devices to have an appearance 263 consistent with medical use. 264 15. Each edible must be individually sealed in plain, 265 opaque wrapping marked only with the marijuana universal symbol. 266 Where practical, each edible must be marked with the marijuana 267 universal symbol. In addition to the packaging and labeling 268 requirements in subparagraphs 11. and 12., edible receptacles 269 must be plain, opaque, and white without depictions of the 270 product or images, except that they must include other than the 271 medical marijuana treatment center’s department-approved logo 272 and the marijuana universal symbol. The receptacle must also 273 include the edible’s identity labeling statement as required by 274 21 C.F.R. s. 101.3; the declaration of net quantity of contents 275 as required by 21 C.F.R. s. 101.105(a), (b), and (c); a list of 276 all the edible’s nutrition facts, allergens, and ingredients;, 277 storage instructions;, an expiration date;, a legible and 278 prominent warning to keep away from children and pets;, and a 279 warning that the edible has not been produced or inspected 280 pursuant to federal food safety laws. 281 16. When dispensing marijuana or a marijuana delivery 282 device, a medical marijuana treatment center: 283 a. May dispense any active, valid order for low-THC 284 cannabis, medical cannabis and cannabis delivery devices issued 285 pursuant to former s. 381.986, Florida Statutes 2016, which was 286 entered into the medical marijuana use registry before July 1, 287 2017. 288 b. May not dispense more than a 70-day supply of marijuana 289 within any 70-day period to a qualified patient or caregiver. 290 May not dispense more than one 35-day supply of marijuana in a 291 form for smoking within any 35-day period to a qualified patient 292 or caregiver. A 35-day supply of marijuana in a form for smoking 293 may not exceed 2.5 ounces unless an exception to this amount is 294 approved by the department pursuant to paragraph (4)(f). 295 c. Must have the medical marijuana treatment center’s 296 employee who dispenses the marijuana or a marijuana delivery 297 device enter into the medical marijuana use registry his or her 298 name or unique employee identifier. 299 d. Must verify that the qualified patient and the 300 caregiver, if applicable, each have an active registration in 301 the medical marijuana use registry and an active and valid 302 medical marijuana use registry identification card, the amount 303 and type of marijuana dispensed matches the physician 304 certification in the medical marijuana use registry for that 305 qualified patient, and the physician certification has not 306 already been filled. 307 e. May not dispense marijuana to a qualified patient who is 308 younger than 18 years of age. If the qualified patient is 309 younger than 18 years of age, marijuana may only be dispensed to 310 the qualified patient’s caregiver. 311 f. May not dispense or sell any other type of cannabis, 312 alcohol, or illicit drug-related product, including pipes or 313 wrapping papers made with tobacco or hemp, other than a 314 marijuana delivery device required for the medical use of 315 marijuana and which is specified in a physician certification. 316 g. Must, upon dispensing the marijuana or marijuana 317 delivery device, record in the registry the date, time, 318 quantity, and form of marijuana dispensed; the type of marijuana 319 delivery device dispensed; and the name and medical marijuana 320 use registry identification number of the qualified patient or 321 caregiver to whom the marijuana delivery device was dispensed. 322 h. Must ensure that patient records are not visible to 323 anyone other than the qualified patient, his or her caregiver, 324 and authorized medical marijuana treatment center employees. 325 Section 2. This act shall take effect July 1, 2025.

Official text from the Florida Legislature. Formatting has been adapted for reading on Ratifi.